Digestive Diseases and Sciences

, Volume 56, Issue 5, pp 1557–1564

Optimum Palliation of Inoperable Hilar Cholangiocarcinoma: Comparative Assessment of the Efficacy of Plastic and Self-Expanding Metal Stents

  • Ramu P. Raju
  • Sathya R. Jaganmohan
  • William A. Ross
  • Marta L. Davila
  • Milind Javle
  • Gottumukkala S. Raju
  • Jeffrey H. Lee
Original Article

Abstract

Background

Endoscopic retrograde biliary drainage (ERBD) with plastic or self-expanding metal stents (SEMS) is often performed for palliative care for cholangiocarcinoma.

Objective

The objective was to compare the clinical effectiveness, including stent patency, complication rate, and need for salvage percutaneous transhepatic biliary drainage, of SEMS and plastic stents.

Methods

A total of 100 patients with inoperable cholangiocarcinoma were identified from an endoscopic database from 1/1/01 to 9/30/06 at a tertiary cancer hospital and their clinical history was retrospectively reviewed. All patients were followed to death, re-intervention, or for at least one year. Stent patency and patient survival were estimated by Kaplan–Meier analysis, supplemented by the log-rank test for comparisons between groups.

Results

Forty-eight patients had SEMS placed and 52 patients had plastic stents placed. ERBD was successful in 46 (95.8%) in the SEMS group and 49 (94.2%) in the plastic group (P = 0.67). Median patency times were 1.86 months in the plastic group and 5.56 months in the SEMS group (P < 0.0001). A mean of 1.53 and 4.60 re-interventions were performed in the SEMS and plastic groups, respectively (P < 0.05). Complications occurred in 4/48 (8.3%) in the SEMS group and 4/52 (7.7%) in the plastic group (P = 0.79). Median survival was 9.08 and 8.22 months in the SEMS and plastic stent groups, respectively (P = 0.50).

Conclusion

Metallic stent patency was superior to that of plastic stents in all Bismuth–Corlette classifications of hilar cholangiocarcinoma with similar complication rates. SEMS seem to be cost-effective and, when feasible, should be considered as an initial intervention in patients with inoperable hilar cholangiocarcinoma.

Keywords

Cholangiocarinoma Endoscopic palliation Biliary stenting Malignant hilar biliary obstruction 

References

  1. 1.
    Landis S, Murray T, Bolden S, Wingo P. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Lazarides KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128:1655–1667.CrossRefGoogle Scholar
  3. 3.
    Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–475.PubMedCrossRefGoogle Scholar
  4. 4.
    Cheng JL, Bruno MJ, Bergman JJ, Rauws EA, Tygat GN, Huibregste K. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc. 2002;56:33–39.PubMedCrossRefGoogle Scholar
  5. 5.
    Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1988;47:1–7.CrossRefGoogle Scholar
  6. 6.
    Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–514.PubMedCrossRefGoogle Scholar
  7. 7.
    Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol. 2000;7:55–66.PubMedCrossRefGoogle Scholar
  8. 8.
    Speer AG, Cotton PB, Russell RC, et al. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Pinol V, Castelis A, Bordas JM, et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprothesis for treating malignant biliary obstruction: randomized clinical trial. Radiology. 2002;225:321–324.CrossRefGoogle Scholar
  10. 10.
    Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprothesis versus operative bypass in malignant obstructive jaundice. Gut. 1989;30:1132–1135.PubMedCrossRefGoogle Scholar
  11. 11.
    Sheperd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprothesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988;75:1166–1168.CrossRefGoogle Scholar
  12. 12.
    Liu CL, Lo CM, Lai EC, Fan ST. Endoscopic retrograde cholangiopancreatography and endoscopic endoprothesis insertion in patients with Klatskin tumors. Arch Surg. 1998;133:293–296.PubMedCrossRefGoogle Scholar
  13. 13.
    Ducreux M, Liguory C, Lefebvre JF, et al. Management of malignant hilar biliary obstruction by endoscopy. Dig Dis Sci. 1992;37:778–783.PubMedCrossRefGoogle Scholar
  14. 14.
    Dumas R, Demuth N, Buckley M, et al. Endoscopic bilateral metal stent placement for malignant hilar stenosis: identification of optimal technique. Gastrointest Endosc. 2000;51:334–348.PubMedCrossRefGoogle Scholar
  15. 15.
    Cotton PB. Diagnosis and management of malignant biliary obstruction. In: Sivak MV, ed. Gastroenterologic Endoscopy. 2nd ed. Philadelphia: WB Saunders; 2000:958–975.Google Scholar
  16. 16.
    Kim JY, Kang DH, Choi CW, Kim HW, Park SB, Kim DU. Selective intrahepatic duct cannulation by using a triple-lumen catheter for endoscopic bilateral stenting in hilar cholangiocarcinoma. Gastrointest Endosc. 2010;72:192–198.PubMedCrossRefGoogle Scholar
  17. 17.
    Chang WH, Kartan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic drainage. Gastrointest Endosc. 1998;47:354–362.PubMedCrossRefGoogle Scholar
  18. 18.
    Libby ED, Leung JW. Prevention of biliary stent clogging: a clinical review. Am J Gastroenterol. 1996;91:1301–1308.PubMedGoogle Scholar
  19. 19.
    Huibregtse K, Carr-Locke DL, Cremer M, et al. Biliary stent occlusion- a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy. 1992;24:391–394.PubMedCrossRefGoogle Scholar
  20. 20.
    Katsinelos P, Paikos D, Kountouras J, et al. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness. Surg Endosc. 2006;51:23–27.Google Scholar
  21. 21.
    O’Brien S, Hatfield AR, Craig P, Williams SP. A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut. 1995;36:618–621.PubMedCrossRefGoogle Scholar
  22. 22.
    Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988;12:39–47.PubMedCrossRefGoogle Scholar
  23. 23.
    Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc. 1998;34:412–417.CrossRefGoogle Scholar
  24. 24.
    Siegal JH, Pullano WE, Wright G. The ultimate large caliber endoprothesis, F Poisseuille was right, bigger is better. Gastrointest Endosc. 1985;31:158–159.Google Scholar
  25. 25.
    Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.PubMedCrossRefGoogle Scholar
  26. 26.
    De Palma GD, Pezzullo A, Rega M, et al. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc. 2003;58:50–53.PubMedCrossRefGoogle Scholar
  27. 27.
    Naitoh I, Ohara N, Nakazawa T, et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gastroenterol Hepatol. 2009;24:552–557.PubMedCrossRefGoogle Scholar
  28. 28.
    Rerknimitr R, Kladcharoen N, Mahachai V, Kullavanijaya P. Results of endoscopic biliary drainage in hilar cholangiocarcinoma. J Clin Gastroenterol. 2004;38:518–523.PubMedCrossRefGoogle Scholar
  29. 29.
    Lammer J, Hausegger K, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201:167–172.PubMedGoogle Scholar
  30. 30.
    Yoon WJ, Lee JK, Lee KH, et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2006;63:996–1000.PubMedCrossRefGoogle Scholar
  31. 31.
    Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endoscop. 2003;57:178–182.CrossRefGoogle Scholar
  32. 32.
    Levy MJ, Baron TH, Gostout CJ, Peterson BT, Farnell MB. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Gastroenterol Hepatol. 2004;2:273–285.CrossRefGoogle Scholar
  33. 33.
    Nicholson DA, Chetty N, Jackson JE, Roddie ME, Adam A. Patency of side branches after peripheral placement of metallic biliary endoprothesis. J Vasc Interv Radiol. 1992;3:127–130.PubMedCrossRefGoogle Scholar
  34. 34.
    Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 1994;35:467–470.PubMedCrossRefGoogle Scholar
  35. 35.
    Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488–1492.PubMedCrossRefGoogle Scholar
  36. 36.
    Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1998;49:466–471.CrossRefGoogle Scholar
  37. 37.
    Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97:898–904.PubMedCrossRefGoogle Scholar
  38. 38.
    Moss AC, Morris E, Leyden J, MacMathuna P. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19:1119–1124.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Ramu P. Raju
    • 1
  • Sathya R. Jaganmohan
    • 1
  • William A. Ross
    • 1
  • Marta L. Davila
    • 1
  • Milind Javle
    • 2
  • Gottumukkala S. Raju
    • 1
  • Jeffrey H. Lee
    • 1
  1. 1.Department of Gastroenterology, Hepatology, and NutritionMD Anderson Cancer CenterHoustonUSA
  2. 2.Department of Gastrointestinal Medical OncologyMD Anderson Cancer CenterHoustonUSA

Personalised recommendations